Rosiglitazone in Treating Patients With Liposarcoma

NCT00004180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: rosiglitazone maleate

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]